Transformation of the Clinical Trials Ecosystem

9:00 am - 10:30 am PDT

Today’s clinical trials require greater collaboration and alignment between health provider and life sciences organizations to conduct trials under rapid and safe protocols that accelerate time to therapeutic evaluation and ultimately time to market.

Join our distinguished panelists from University of California School of Medicine, Hackensack Meridian Health, Bayer Healthcare Pharmaceuticals, Boehringer Ingelheim, and Tenet Healthcare for a discussion on:

• Critical clinical trials topics including improving the patient experience and streamlining the Principal Investigator (PI) experience
• Perspective on managing clinical trials risk and compliance
• The role of technology and how to integrate it into existing enterprise technology for desired outcomes

Hosted by EY and Pegasystems

Panelists
Dr. Daniela Bota
Vice Dean for Clinical Research, Medical Director, Center for Clinical Research
University of California School of Medicine, Irvine

Dr. Klaus Peter Kammerer
Global Head of Clinical Development
Boehringer Ingelheim Pharmaceuticals

Howard Hacker
Executive Vice President and Chief Compliance Officer
Tenet Healthcare

Mark Ryan
Vice President, Head of Site Management, Americas Region
Bayer Healthcare Pharmaceuticals

Dr. Ihor Sawczuk
Regional President, Northern Market
Chief Research and Institutional Officer
Hackensack Meridian Health

Salman Shah
Partner / Principal
EY

Kelli Bravo
Vice President, Global Industry Market Leader, Healthcare and Life Sciences
Pegasystems